Related content

Effects of rosiglitazone on endothelial function, C-reactive protein, and components of the metabolic syndrome in nondiabetic patients with the metabolic syndrome

By Wang T.-D.   Chen W.-J.   Lin J.-W.   Chen M.-F.   Lee Y.-T.  

The American Journal of Cardiology, Vol. 93, Iss. 3, 2004-02 ,pp. : 362-365

Elsevier

Access to resources Recommend Favorite

C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men

By Laaksonen D.   Niskanen L.   Nyyssönen K.   Punnonen K.   Tuomainen T.-P.   Valkonen V.-P.   Salonen R.   Salonen J.  

Diabetologia, Vol. 47, Iss. 8, 2004-08 ,pp. : 1403-1410

Springer Publishing Company

Access to resources Recommend Favorite

C-reactive protein: history and revival

By Ablij H.C.   Meinders A.E.  

European Journal of Internal Medicine, Vol. 13, Iss. 7, 2002-10 ,pp. : 412-422

Elsevier

Access to resources Recommend Favorite

C-Reactive Protein and Atherosclerosis: An Update

By  

Vascular Disease Prevention, Vol. 5, Iss. 3, 2008-08 ,pp. : 178-182

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of metformin and sulfonylurea on C-reactive protein level in well-controlled type 2 diabetics with metabolic syndrome

By Akbar Daad  

Endocrine Journal, Vol. 20, Iss. 3, 2003-04 ,pp. : 215-218

Humana Press, Inc

Access to resources Recommend Favorite